Clinical Trial

Human Microbiome Research and Development for Overcoming Pediatric Diseases

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.
Trial Details
NCT Number NCT06812091
Lead Sponsor Hanyang University
Conditions Human Microbiome, Pediatrics, Disease, Growth & Development
Enrollment 500 participants
Start Date 2022-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-06